BioGX is offering all COVID-19 products non-exclusively. Please contact us if you are interested in being a distributor.
For unrepresented territories, please contact BioGX BV directly.
Phone: +31 20 893 4261
Phone: +1 800 640 0640
Axon Lab AG
Phone: +43 523 88 77 66
Axon Lab NV
Phone: +32 2 311 52 62
Phone: +359 2 9621755
Phone: +56 02 2264 0836
Beijing Asnail Biotechnology
Beijing, Shanghai, Shenzhen (North, Mid-latitude, South)
Phone: +86 10 64368082
Shenzhen BST Science and Technology Co., LTD
Central and Southern China
Phone: +86 755 25537800
Axon Lab d.o.o.
Phone: +385 1 580 72 83
Axon Lab spol. s r. o.
Phone: +4 20 326 921 318
Axon Lab AG
Phone: +49 7153 9226 0
Launch Diagnostics France SAS
Phone: +33 805 119 482
Phone: +354 580 3900
A Division of Launch Diagnostics Limited
Phone: +353 1 232 1038 / +44 1474 874426
Phone: +39 6 508 9499
Issac Healthcare Services Co. W.L.L.
Phone: +965 222 782 23
Axon Lab BV
Phone: +31 88 003 66 00
Ngaio Diagnostics Limited
New Zealand, Pacific Islands
Phone: +64 3 548 4727
Phone: +351 219 236 350
Phone: +40 31 401 10 90
Axon Lab d.o.o.
Phone: +386 59 33 44 90
Microanalytica (Pty) Ltd
South Africa, Sub-Saharan Africa
Phone: +27 60 999 9140
Axon Lab AG
Phone: +41 56 484 80 80
Bond Biotech., Inc.
Phone: +886 4 2358 3959
Phone: +63 2 635 0980
Phone: +90 342 360 65 00
Launch Diagnostics Limited
Phone: +44 1474 874426
For US inquiries: INFO@BIOGX.COM | +184.108.40.20655
For EU inquiries: EU@BIOGX.COM | +31.20.893.4261
QuantStudio™ 5 Extracted Sample Run File 1
QuantStudio™ 5 Extracted Sample PDF
CFX96 Touch™ Extracted Sample Run File 1
CFX96 Touch™ Extracted Sample Run File 2
CFX96 Touch™ Extracted Sample PDF
QuantStudio™ 5 Direct Sample Run File and QuantStudio™ 5 Direct Sample PDF
CFX96 Touch™ Direct Sample Run File 1, CFX96 Touch™ Direct Sample Run File 2 and CFX96 Touch™ Direct Sample PDF
This Fact Sheet informs you of the significant known and potential risks and benefits of the use of the BioGX Xfree™ COVID-19 Direct RT-PCR. The BioGX Xfree™ COVID-19 Direct RT-PCR is validated for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.
Healthcare Provider Fact Sheet
Patient Fact Sheet
Dr. Shahin Iqbal joined BioGX in 2019. Dr. Iqbal is the Senior Vice President of Global Operations at BioGX and has over 20 years of experience in clinical and molecular diagnostics. Before joining BioGX, Dr. Iqbal led the Abbott Diagnostics Global Service & Support specifically for informatics, core lab automation, immunoassay and clinical chemistry systems at Abbott Diagnostics. He was also responsible for design and development of FISH automation systems at Abbott Molecular. He is the recipient of the President awards and multiple service & innovation awards at Abbott. Dr. Iqbal holds multiple patents on optical sensors for covers slips, automation systems development, RFID applications and robotics for system dispensing. Prior to joining Abbott, Dr. Iqbal was head of operations, quality & regulatory, systems development and manufacturing of IHC systems at BioGenex in California. Dr. Iqbal has an MBA and Ph.D as well as a Masters in Electrical Engineering degree from the University of Texas in San Antonio.
Dr. Shazi Iqbal joined BioGX in 2011 as Chief Executive Officer of the Company. Dr. Shazi Iqbal has over 20 years of experience building healthcare technologies and businesses in business development, corporate sales, global marketing and product development. Previously, Dr. Iqbal worked as Director of CSR Program and Corporate Programs, concurrently leading Cepheid’s custom reagents business and GeneXpert commercialization strategy and sales execution for Veterans Affairs, Department of Defense, national hospital networks and Group Purchasing Organizations. Prior to Cepheid, he served as Head of Global Marketing and Business Development for BioGenex, a cancer diagnostics company. Dr. Iqbal has co-founded SYFR, MicroGen Systems, GeneXpress Informatics and CodeMD. He started his career as a Senior Scientist at Systems & Processes Engineering Corporation (SPEC). Dr. Iqbal received a Ph.D. in Biology from University of Texas at San Antonio, holds two master’s degrees in Biochemistry and Biotechnology and has several patents and publications to his name. He lives in the San Francisco Bay Area.
Mr. Curtis joined BioGX in 2016. He is responsible for providing the global infrastructure, process and technology for BioGX’s global operations. With more than 20 years in the technology and operations industry, he has also served in various Operations and IT leadership positions at Battelle Memorial Institute, Nationwide Insurance and Cardinal Health. Mr. Curtis has spent much of his career leading Operation and IT consolidations, Cloud technology identification and implementation, process design, improvement and efficiency initiatives. Mr. Curtis studied Management Information Systems and Marketing at Franklin University.
Mr. Mohammed Merchant joined BioGX in 2020 as Senior Director of Digital Product Management & Marketing, responsible for managing all digital applications and assets. He brings over 20 years of experience in digital technology, e-commerce, and software product management in various industries and has held product leadership roles at Sprint, Travelocity, Capital One, Sabre, and cxLoyalty. Mr. Merchant has a proven track record of taking complex business needs and transforming them into successful digital and mobile products and solutions. He holds an MBA and MS Innovation and Entrepreneurship degrees from University of Texas in Dallas and received his BS in Management Information Systems from Oklahoma State University.
Dr. Martinez joined BioGX in 2015. Dr. Martinez manages global marketing of BioGX manufacturing services; expanding our portfolio of IVD products; managing the global technical support efforts of all molecular diagnostic products; and manages a team of scientists responsible for product and technology innovation in conjunction with existing corporate partnerships. Dr. Martinez has over 20 years of experience in molecular biology. Prior to joining BioGX, Dr. Martinez held research positions focusing on cancer cell biology at Albany Medical College, microbial community dynamics at The Georgia Institute of Technology and microbial physiology at The University of Alabama. Dr. Martinez holds a BA in Biology from Boston University and a Ph.D. in Microbiology from The Georgia Institute of Technology.
Dr. Vickery founded BioGX in 2007 and served as President and CEO until 2011. Prior to founding BioGX, Dr. Vickery worked in sales and as a technical consultant at Cepheid. Prior to Cepheid, Dr. Vickery worked at the FDA as a University of Maryland JIFSAN postdoctoral fellow at the University of Maryland, and later served as the Lead for Molecular Methods Development at the U.S. FDA Gulf Coast Seafood Laboratory. He holds multiple patents in biotechnology, has authored or co-authored many publications, and has extensive experience in gene expression analysis, and in the design and development of rapid multiplex molecular tests for microbial and viral detection. Dr. Vickery holds a B.S. degree in Physics and both M.S. and Ph.D. degrees in Biology (molecular biology and molecular genetics focus – both prokaryotic and eukaryotic). Prior to entering graduate school, Dr. Vickery worked as an executive in the lowbed trailer industry for almost 10 years, pioneering the sale of American made heavy equipment transport trailers into China (ROC) and Japan during his tenure in the industry, and resupplying the oilfields of Kuwait with specialized trailers after the Gulf War.
Mr. Hughes joined BioGX in 2015. Prior to joining BioGX, Mr. Hughes led efforts for a diverse range of companies with the development and implementation of certified quality management systems ranging from data storage devices with SONY Corporation, security & detention devices with Norment Security Group, textile manufacturing with Twitchell Corporation, combat vehicle manufacturing with General Dynamics, and therapeutic medical devices with Steris Corporation. Christopher has a BSE from Auburn University and an MBA from Troy State University.
Mr. Blackstone joined BioGX in 2007. He has served at BioGX in various senior R&D and quality management roles prior to his current position as Senior Director of Product Development. Mr. Blackstone has designed and directed the development of over 100 multiplex real time PCR products in the fields of food safety, water quality, pharma QC, and clinical diagnostics. Mr. Blackstone previously served for eight years at the US Food and Drug Administration and as a Commissioned Research Officer in the US Public Health Service Commissioned Corps where he achieved the rank of Lieutenant Commander. George Blackstone received his Master of Science degree from Louisiana State University.